Related Experiment Video
Updated: Dec 31, 2025

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
[IMPACT OF LIPOSOMAL VITAMIN C AND VITAMIN E COMPLAX ON NORMAL AND TUMOR CELLS]
T Sanikidze1, E Shekiladze1, M Enukidze1
1Tbilisi State Medical University, V. Bakhutashvili Institute of Medical Biotechnology; I. Javakhishvili Tbilisi State University, Georgia.
Abstract:
In order to assess the possibility of using liposomes to stabilize various antioxidant compounds, we investigated the effect of liposomes (1,2-palmitoyl-phosphatidic acid (DPPA) and dipalmitoylphosphatidylcholine (DPPC)) on the effectiveness of antioxidants, hydrophilic vitamin C and lipophilic vitamin E, in model systems of normal epithelial MDCK cells and tumor Jurkat T cells. The effect of vitamins C, E and (C + E) in combination with DPPC and DPPA liposomes on Jurkat and MDCK cells depends on the dissolution or integration of these liposomes with hydrophobic sections of the cellular membrane, as well as the subsequent release of vitamins from liposomes. Based on the results of the study, it can be concluded that the studied liposomes can modulate the effects of C and E vitamins on normal and tumor cells. These data can be used to study the possible selective regulation of the activity of various hydrophobic and hydrophilic antioxidants on normal and tumor cells, which is especially important for creating antitumor drugs, as well as effective radioprotectors that protect healthy tissues from radiation damage during radiotherapy.
More Related Videos
09:00Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
Published on: August 18, 2016
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Tumor Microenvironment
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...